JPH0632622B2 - Method for producing immobilized cells - Google Patents
Method for producing immobilized cellsInfo
- Publication number
- JPH0632622B2 JPH0632622B2 JP25275886A JP25275886A JPH0632622B2 JP H0632622 B2 JPH0632622 B2 JP H0632622B2 JP 25275886 A JP25275886 A JP 25275886A JP 25275886 A JP25275886 A JP 25275886A JP H0632622 B2 JPH0632622 B2 JP H0632622B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- immobilized
- phenylalanine
- reaction
- immobilized cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明は固定化菌体の製法に関する。該固定化菌体は酵
素反応により種々の物質、例えば、アミノ酸を製造する
のに有用である。TECHNICAL FIELD The present invention relates to a method for producing immobilized cells. The immobilized bacterial cells are useful for producing various substances such as amino acids by enzymatic reaction.
従来の技術 酵素をグルタルアルデヒドや高分子物質で固定化するこ
と及び補酵素をヘキサメチレンジアミンで固定化するこ
とは知られている。〔千畑一郎編;固定化酵素、(株)
講談社(1975)〕。酵素又は微生物菌体をカラギーナンで
固定した後、グルタルアルデヒドとヘキサメチレンジア
ミンで処理することは知られている〔福井、千畑、鈴木
編;酵素工学、東京化学同人(1981)〕。BACKGROUND ART It is known to immobilize an enzyme with glutaraldehyde or a polymer substance and immobilize a coenzyme with hexamethylenediamine. [Edited by Ichiro Chibata; Immobilized Enzyme, Inc.]
Kodansha (1975)]. It is known that an enzyme or microbial cell is fixed with carrageenan and then treated with glutaraldehyde and hexamethylenediamine [Fukui, Chibata, Suzuki, Enzyme Engineering, Tokyo Kagaku Dojin (1981)].
発明が解決しようとする問題点 長期間繰り返して使用できる固定化菌体の開発が求めら
れている。Problems to be Solved by the Invention There is a demand for the development of immobilized cells that can be repeatedly used for a long period of time.
問題点を解決するための手段 本発明方法によると、菌体をジアミンとジアルデヒドと
で処理した後、該処理物を高分子物質で固定化すること
により、長期間繰り返し使用に耐える固定化菌体を得る
ことができる。Means for Solving the Problems According to the method of the present invention, an immobilized bacterium that can be used repeatedly for a long period of time by treating cells with a diamine and dialdehyde and then immobilizing the treated product with a polymer substance. You can get the body.
本発明に用いられるジアミンとしては、アミノ基を二個
有する分子量200以下の化合物、例えば、エチレンジ
アミン、トリメチレンジアミン、テトラメチレンジアミ
ン、ペンタメチレンジアミン、ヘキサメチレンジアミ
ン、トリエチレンテトラミン、1,7−ジアミノヘプラ
ン、1,8−ジアミノオクタン、1,10−ジアミノデカン等
があげられる。The diamine used in the present invention is a compound having two amino groups and having a molecular weight of 200 or less, for example, ethylenediamine, trimethylenediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, triethylenetetramine, 1,7-diamino. Heplan, 1,8-diaminooctane, 1,10-diaminodecane and the like can be mentioned.
ジアルデヒドとしては、炭素数10以下の脂肪族又は芳
香族アルデヒド、例えばグリオキサール、マロンアルデ
ヒド、スクシンアルデヒド、グルタルアルデヒド、アジ
ピンアルデヒド、ピメリンアルデヒド、スベリンアルデ
ヒド、アゼラインアルデヒド、セバシンアルデヒド、マ
レインアルデヒド、フマルアルデヒド、フタルアルデヒ
ド、イソフタルアルデヒド、テレフタルアルデヒド等が
あげられる。Examples of the dialdehyde are aliphatic or aromatic aldehydes having 10 or less carbon atoms, such as glyoxal, malonaldehyde, succinaldehyde, glutaraldehyde, adipine aldehyde, pimelin aldehyde, suberin aldehyde, azelain aldehyde, sebacin aldehyde, malein aldehyde, and fumaraldehyde. Examples thereof include aldehyde, phthalaldehyde, isophthalaldehyde, terephthalaldehyde and the like.
高分子物質としては、ポリビニルアルコールゲル、ポリ
アクリルアミドゲル、カラギーナン、アルギン酸ナトリ
ウム等があげられる。Examples of the polymer substance include polyvinyl alcohol gel, polyacrylamide gel, carrageenan, sodium alginate and the like.
本発明に用いられる菌体としては、細菌、放線菌、糸状
菌、酵母、カビ、藻類等の菌体があげられる。本発明方
法は特に、菌体からの酵素漏出が著しいものに有効であ
る。具体的にはサルモネラ属、シトロバクター属等に属
する微生物の菌体があげられる。該微生物の代表例とし
ては、サルモネラ・チフィムリウム(Salmonella typhim
urium)ATCC19585及びシトロバクター・フロインディ(Ci
trobacter freundi)ATCC 6750があげられる。Examples of the bacterial cells used in the present invention include bacterial cells such as bacteria, actinomycetes, filamentous fungi, yeasts, molds and algae. The method of the present invention is particularly effective for those in which enzyme leakage from bacterial cells is remarkable. Specific examples include cells of microorganisms belonging to the genus Salmonella, the genus Citrobacter and the like. As a typical example of the microorganism, Salmonella typhimurium (Salmonella typhim
urium) ATCC 19585 and Citrobacter Freundi (Ci
trobacter freundi) ATCC 6750.
本発明において、微生物菌体をジアミンとジアルデヒド
とで処理するには、微生物の培養液にジアミンとジアル
デヒドを添加するか、培養液から微生物菌体を分離した
後、該菌体をジアミンとジアルデヒドとを含む溶液に懸
濁してもよい。使用するジアミンとジアルデヒドとの重
量は共に微生物菌体の乾燥重量の1/100〜5倍、好まし
くは1/10〜1/2倍の範囲である。微生物菌体を処理する
液中のジアミン及びジアルデヒドの濃度は共に0.1〜5
%、好ましくは1〜3%の範囲である。処理は温度1〜
40℃、好ましくは4〜25℃、0.5〜3時間、好まし
くは1〜2時間、pH5〜8、好ましくは6〜7で行う。In the present invention, in order to treat microbial cells with diamine and dialdehyde, diamine and dialdehyde are added to the culture solution of the microorganism, or after separating the microbial cells from the culture solution, the microbial cells with diamine. It may be suspended in a solution containing dialdehyde. The weights of the diamine and dialdehyde used are both 1/100 to 5 times, preferably 1/10 to 1/2 times the dry weight of the microbial cells. The concentration of diamine and dialdehyde in the liquid for treating microbial cells is both 0.1 to 5
%, Preferably 1 to 3%. Treatment is temperature 1
It is carried out at 40 ° C, preferably 4 to 25 ° C, 0.5 to 3 hours, preferably 1 to 2 hours, and pH 5 to 8, preferably 6 to 7.
上記の如くして、菌体処理物を得る。A treated bacterial cell product is obtained as described above.
前記菌体処理物を高分子物質で固定化する場合には、例
えば、次の様に行う。When the treated bacterial cell product is immobilized with a polymeric substance, it is carried out, for example, as follows.
ポリビニルアルコールを用いる場合には、菌体処理物を
ポリビニルアルコール水溶液に加え混合した後、凍結
し、融解する。When polyvinyl alcohol is used, the treated cells are added to an aqueous polyvinyl alcohol solution, mixed, and then frozen and thawed.
ポリアクリルアミドゲルを用いる場合には、アクリルア
ミドと架橋剤(例えばN,N′−メチレンビスアクリルア
ミド)を溶解した緩衝液に菌体処理物を懸濁させ、重合
促進剤(例えば、β−ジメチルアミノプロピオニトリル
及び重合開始剤(例えば、過硫酸カリウム)を加えて重
合する。When a polyacrylamide gel is used, the treated cells are suspended in a buffer solution in which acrylamide and a cross-linking agent (for example, N, N'-methylenebisacrylamide) are dissolved, and a polymerization accelerator (for example, β-dimethylaminoproton) is suspended. Polymerization is performed by adding pionitrile and a polymerization initiator (eg, potassium persulfate).
カラギーナン及びアルギン酸ナトリウムを用いる場合に
は、菌体処理物をカラギーナン又はアルギン酸ナトリウ
ム水溶液に加え混合した後、該混合液を塩化カリウム
(アルギン酸ナトリウムの場合は塩化カルシウム)水溶
液に滴下する。When using carrageenan and sodium alginate, the treated cells are added to and mixed with the carrageenan or sodium alginate aqueous solution, and then the mixed solution is added dropwise to an aqueous potassium chloride (calcium chloride in the case of sodium alginate) aqueous solution.
反応液から固定化菌体を分離する方法としては、遠心分
離方法、過方法等がある。As a method for separating the immobilized cells from the reaction solution, there are a centrifugation method, an excess method and the like.
以下実施例を示す。Examples will be shown below.
実施例1 グルコース5%、コーンスチープリカー2%、硫酸アン
モニウム1%、リン酸一カリウム0.05%、リン酸二カリ
ウム0.05%及び硫酸マグネシウム・7水和物0.025%か
らなる培地(pH7)にサルモネラ・チフィムリウムATCC 19
585を培養して得られた湿菌体50g(乾燥重量12
g)をアジピンアルデヒド2%及びトリエチレンテトラ
ミン2%を含む0.2Mリン酸緩衝液(pH7) 150mlに
懸濁し、4℃で3時間放置した。ついで、該懸濁液から
菌体を遠心分離した後、該菌体を生理食塩水150ml
で2回洗浄した。該洗浄した菌体をゴーセノールNH−
26〔ポリビニルアルコール,日本合成工業(株)製〕
の20%水溶液50gと混合し、−20℃で18時間放
置した後、解凍して3〜4mm角に細断して固定化菌体を
得た。該固定化菌体をフェニルピルビン酸0.2M、アス
パラギン酸ナトリウム0.24M及びリン酸ピリドキサール
0.01mMからなる基質液(pH7)100mlに懸濁させ、3
5℃で24時間反応させフェニルアラニン2.9gを得
た。反応後、固定化菌体を金網により回収し、回収した
固定化菌体を新しい基質液に懸濁させて2回目の反応を
行った。このようにして繰り返し反応を行ったところ、
反応15回目におけるフェニルアラニンの生成量は2.3
gであった。Example 1 Salmonella typhimurium was added to a medium (pH 7) containing 5% glucose, 2% corn steep liquor, 1% ammonium sulfate, 0.05% monopotassium phosphate, 0.05% dipotassium phosphate and 0.025% magnesium sulfate heptahydrate. ATCC 19
50 g of wet cells obtained by culturing 585 (dry weight: 12
g) was suspended in 150 ml of 0.2 M phosphate buffer (pH 7) containing 2% of adipic aldehyde and 2% of triethylenetetramine, and the suspension was left at 4 ° C. for 3 hours. Then, the bacterial cells were centrifuged from the suspension, and the bacterial cells were washed with 150 ml of physiological saline.
It was washed twice with. The washed cells were treated with Gohsenol NH-
26 [Polyvinyl alcohol, manufactured by Nippon Synthetic Industry Co., Ltd.]
After mixing with 50 g of a 20% aqueous solution of the above, the mixture was left standing at -20 ° C. for 18 hours, thawed and shredded into 3 to 4 mm square pieces to obtain immobilized cells. The immobilized cells were treated with phenylpyruvic acid 0.2M, sodium aspartate 0.24M and pyridoxal phosphate.
Suspend in 100 ml of 0.01 mM substrate solution (pH 7) and
The reaction was carried out at 5 ° C. for 24 hours to obtain 2.9 g of phenylalanine. After the reaction, the immobilized bacterial cells were collected by a wire net, and the recovered immobilized bacterial cells were suspended in a new substrate solution to carry out a second reaction. When the reaction was repeated in this way,
The amount of phenylalanine produced in the 15th reaction was 2.3.
It was g.
一方、対照1として、前記操作と同様に培養したサルモ
ネラ・チフィムリウムATCC 19585の菌体をアジピンアル
デヒド及びトリエチレンテトラミンで前処理することな
く、ゴーセノールNH−26で固定化して、該固定化菌
体をフェニルアラニンの生成反応に用いる以外は前記と
同様な操作により、フェニルアラニンを得た。その結果
として、反応1回目及び15回目におけるフェニルアラ
ニンの生成量はそれぞれ2.9g及び0.1gであった。On the other hand, as Control 1, the cells of Salmonella typhimurium ATCC 19585 cultured in the same manner as the above procedure were immobilized with Gohsenol NH-26 without pretreatment with adipinaldehyde and triethylenetetramine, and the immobilized cells were Phenylalanine was obtained by the same procedure as above except that it was used for the reaction for producing phenylalanine. As a result, the amounts of phenylalanine produced in the first and fifteenth reactions were 2.9 g and 0.1 g, respectively.
対照2として、前記操作と同様に培養したサルモネラ・
チフィムリウムATCC 19585の菌体をゴーセノールNH−
26の20%水溶液50gと混合し、−20℃で18時
間放置した後、解凍して3〜4mm角に細断した固定化菌
体を得た。該固定化菌体をヘキサメチレンジアミン2%
及びグルタルアルデヒド2%を含む0.2Mリン酸緩衝液
(pH7)300mlに懸濁させ、4℃で3時間放置した。
固定化菌体を回収し、回収した固定化菌体を生理食塩水
300mlで2回洗浄した。性能した固定化菌体をフェ
ニルアラニンの生成反応に用い、前記と同様な操作によ
りフェニルアラニンを得た。その結果として、1回目及
び15回目におけるフェニルアラニンの生成量はそれぞ
れ2.9g及び1.7gであった。As a control 2, Salmonella cultured in the same manner as the above operation
Gysenol NH-
The mixture was mixed with 50 g of a 20% aqueous solution of 26, left standing at -20 ° C for 18 hours, then thawed to obtain immobilized cells which were shredded into 3 to 4 mm square pieces. Hexamethylenediamine 2% with the immobilized cells
And 0.2M phosphate buffer containing 2% glutaraldehyde
The suspension was suspended in 300 ml (pH 7) and left at 4 ° C. for 3 hours.
The immobilized cells were recovered, and the recovered immobilized cells were washed twice with 300 ml of physiological saline. Using the immobilized cells that had been used for the reaction for producing phenylalanine, phenylalanine was obtained by the same procedure as described above. As a result, the amounts of phenylalanine produced in the 1st and 15th cycles were 2.9 g and 1.7 g, respectively.
実施例2及び3 実施例1において、第1表に示すジアミン及びジアルデ
ヒドを用いる以外は実施例1と同様にして第1表に示す
結果を得た。Examples 2 and 3 The results shown in Table 1 were obtained in the same manner as in Example 1 except that the diamine and dialdehyde shown in Table 1 were used.
実施例4 シトロバクター・フロインディATCC 6750を実施例1と
同組成の培地に培養して得られた湿菌体50g(乾燥重
量12g)を2%ヘキサメチレンジアミン水溶液(塩酸
でpH7に調整したもの)150mlに懸濁し、25℃で
攪拌しながら、25%グルタルアルデヒド水溶液12m
lを15分間で滴下した。滴下中、液のpHは5%アンモ
ニア水で6〜7に維持した。さらに、30分間攪拌を続
けた後、懸濁液から菌体を遠心分離し、該菌体を生理食
塩水200mlで2回洗浄した。該洗浄した菌体をソア
ギーナMV−101〔カラギーナン,三菱アセテート
(株)製〕の3%水溶液50gに懸濁させ、該懸濁液を
5%塩化カリウム水溶液に滴下して、約5mm径の球状固
定化菌体を得た。該固定化菌体をフェニルピルビン酸ナ
トリウム0.2M、フマル酸二アンモニウム0.3M、リン酸
ピリドキサール0.01mM、亜硫酸ナトリウム・7水和物0.
05%及び塩化マグネシウム0.005%からなる基質液(pH7)
50mlに懸濁させ、30℃で24時間反応させフェニ
ルアラニン1.5gを得た。 Example 4 50 g (12 g dry weight) of wet bacterial cells obtained by culturing Citrobacter freundii ATCC 6750 in a medium having the same composition as in Example 1 was adjusted to pH 7 with a 2% hexamethylenediamine aqueous solution (hydrochloric acid). ) Suspend in 150 ml and stir at 25 ° C. while stirring 25% glutaraldehyde aqueous solution 12 m
1 was added dropwise over 15 minutes. During the dropping, the pH of the liquid was maintained at 6 to 7 with 5% aqueous ammonia. After further stirring for 30 minutes, the bacterial cells were centrifuged from the suspension, and the bacterial cells were washed twice with 200 ml of physiological saline. The washed cells were suspended in 50 g of a 3% aqueous solution of Soagina MV-101 [carrageenan, manufactured by Mitsubishi Acetate Co., Ltd.], and the suspension was added dropwise to a 5% potassium chloride aqueous solution to form a spherical particle having a diameter of about 5 mm. Immobilized cells were obtained. The immobilized cells were treated with sodium phenylpyruvate 0.2 M, diammonium fumarate 0.3 M, pyridoxal phosphate 0.01 mM, sodium sulfite heptahydrate.
Substrate solution (pH 7) consisting of 05% and magnesium chloride 0.005%
It was suspended in 50 ml and reacted at 30 ° C. for 24 hours to obtain 1.5 g of phenylalanine.
反応後、固定化菌体を金網により回収し、回収した固定
化菌体を新しい基質液に懸濁させて2回目の反応を行っ
た。この様にして繰り返し反応を行ったところ、反応6
0回目おけるフェニルアラニンの生成量は1.5gであっ
た。After the reaction, the immobilized bacterial cells were collected by a wire net, and the recovered immobilized bacterial cells were suspended in a new substrate solution to carry out a second reaction. When the reaction was repeated in this manner, reaction 6
The amount of phenylalanine produced in the 0th cycle was 1.5 g.
一方、対照1として、前記操作において、ヘキサメチレ
ンジアミン及びグルタルアルデヒドの代わりにヘキサメ
チレンジアミンを用いる以外は前記と同様にしてフェニ
ルアラニンの生成を行った。その結果、1回目及び10
回目のフェニルアラニンの生成量はそれぞれ1.5g及び
0.1gであった。On the other hand, as Control 1, phenylalanine was produced in the same manner as described above except that hexamethylenediamine was used instead of hexamethylenediamine and glutaraldehyde in the above operation. As a result, the first time and 10
The amount of phenylalanine produced for the first time was 1.5 g and
It was 0.1 g.
対照2として、前記操作において、ヘキサメチレンジア
ミン及びグルタルアルデヒドを用いない以外は前記と同
様にしてフェニルアラニンの生成を行った。その結果、
1回目及び20回目のフェニルアラニンの生成量はそれ
ぞれ1.5g及び0.2gであった。As Control 2, phenylalanine was produced in the same manner as above except that hexamethylenediamine and glutaraldehyde were not used in the above operation. as a result,
The amounts of phenylalanine produced in the 1st and 20th cycles were 1.5 g and 0.2 g, respectively.
発明の効果 本発明方法により、長期間繰り返し使用できる固定化菌
体を得ることができる。Effect of the Invention According to the method of the present invention, it is possible to obtain immobilized cells that can be repeatedly used for a long period of time.
Claims (1)
た後、該処理物を高分子物質で固定化することを特徴と
する固定化菌体の製法。1. A method for producing an immobilized microbial cell, which comprises treating the microbial cell with a diamine and a dialdehyde and then immobilizing the treated product with a polymer substance.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25275886A JPH0632622B2 (en) | 1986-10-23 | 1986-10-23 | Method for producing immobilized cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25275886A JPH0632622B2 (en) | 1986-10-23 | 1986-10-23 | Method for producing immobilized cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63105678A JPS63105678A (en) | 1988-05-10 |
| JPH0632622B2 true JPH0632622B2 (en) | 1994-05-02 |
Family
ID=17241879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25275886A Expired - Lifetime JPH0632622B2 (en) | 1986-10-23 | 1986-10-23 | Method for producing immobilized cells |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0632622B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2244711B (en) * | 1990-06-06 | 1994-04-06 | Chulalongkorn University | Immobilized enzymes with process for the production of 6-aminopenicillanic acid |
| CN117757688B (en) * | 2023-12-28 | 2024-06-25 | 中国水产科学研究院珠江水产研究所 | Citrobacter freundii JYS, and microbial inoculum and application thereof |
-
1986
- 1986-10-23 JP JP25275886A patent/JPH0632622B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63105678A (en) | 1988-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3163224B2 (en) | Method of storing cells or suspension of immobilized cells | |
| EP0054800B1 (en) | Process for the production of immobilized microorganisms | |
| CA2676926A1 (en) | Induction of enzymatic activity in nitrile hydratase-producing bacteria | |
| JPS6156086A (en) | Microbial preparation of alpha-hydroxyacid and its salt | |
| JPH0632622B2 (en) | Method for producing immobilized cells | |
| JPS58162293A (en) | Preparation of immobilized microorganism | |
| JPH08154691A (en) | Method for producing amide compound | |
| JPS6131085A (en) | Preparation of immobilized microbial cell | |
| JPH02242690A (en) | Production method of L-alanine | |
| JP2830029B2 (en) | Method of removing fumarase activity | |
| JPS60126092A (en) | Method for producing L-aspartic acid | |
| JPS60120983A (en) | Culture of bacterial cell belonging to brevibacterium genus | |
| JPH0591895A (en) | Method for producing D-serine | |
| JPH02207794A (en) | How to remove fumarase activity | |
| JPS6012037B2 (en) | Production method of itaconic acid using immobilized microorganisms | |
| JPS62163698A (en) | Production of gamma-l-glutamyl-l-alpha-amino-n-butyrylglycine | |
| JPH01256389A (en) | Production of immobilized biocatalyst | |
| JPS5915629B2 (en) | Antibiotic manufacturing method | |
| JPS60156394A (en) | Preparation of l-2-amino-4-phenylbutyric acid | |
| JPH05168481A (en) | Preparation method of immobilized gel including biocatalyst and its use | |
| JPH03266994A (en) | Production of l-tyrosine | |
| JPS5944039B2 (en) | Method for producing L-glutamic acid | |
| JPH03266993A (en) | Production of l-tyrosine | |
| JPH0361479A (en) | Culture method for microorganism | |
| WO2005095626A1 (en) | Immobilized biocatalyst and process for producing organic acid salt with the same |